Infectious Disease Point of Care Diagnostics Market Size and Forecast to 2030.

The report "Infectious Disease Point of Care Diagnostics Market by Product Type (Infectious Disease Testing Kits & Reagents, Haematology Testing Kits, Urinalysis Testing Kits, Others), by Disease Condition (Bacterial Infections, Fungal Infections, Viral Infections, Cardiovascular Infections, GI Infections, Sexually Transmitted Disease, CNS Infections, Other), by Prescription Mode (Over-The-Counter (OTC) Testing Kits, Prescription-based Testing Kits), by End User (Professional Diagnostic Centres, Homecare, Others), - Global Forecasts to 2030"

The global Infectious Disease Point of Care Diagnostics Market is projected to reach USD 2,747.8?million in 2023, registering at a Compound Annual Growth Rate (CAGR) of 8.2% during the forecast period 2024-2030.

Request sample report at https://www.precisionbusinessinsights.com/request-sample/?product_id=16259? ?

Competitive Dashboard: The prominent key players operating in the global Infectious Disease Point of Care Diagnostics Market are Cepheid Inc. (Danaher Corporation) (U.S.) Abbott Laboratories, Inc. (U.S.) F. Hoffmann La Roche Limited (Switzerland) Beckman Coulter, Inc. (U.S.) Siemens Healthcare GmbH (Germany) Johnson & Johnson Services, Inc. (U.S.) Instrumentation Laboratory (U.S.) Becton, Dickinson and Company (U.S.) Alere Inc. (U.S.) Nova Biomedical (U.S.) Thermo Fisher Scientific (U.S.) Quidel Corporation (U.S.)

Regional Overview: The report also examines the current concerns and their Future Effects on the Infectious Disease Point of Care Diagnostics Market by the region. The report covers all regions and countries, North America was the largest and Asia was the fastest-growing region in the Infectious Disease Point of Care Diagnostics Market. The market has been segmented into numerous primary regions and a detailed evaluation of primary countries.

• North America (U.S., Canada)
• Europe (Germany, U.K., France, Italy, Russia, Spain, Rest of Europe)
• Asia-Pacific (China, India, Japan, Australia, Southeast Asia, Rest of Asia Pacific)
• Latin America (Mexico, Brazil, Argentina, Columbia, Rest of Latin America)
• Middle East & Africa (GCC, Egypt, Nigeria, South Africa, Rest of Middle East and Africa)

A Few Points from the Table of Contents?–

1. Executive Summary

2. Global Infectious Disease Point of Care Diagnostics Market Introduction

3. Global Infectious Disease Point of Care Diagnostics Market Dynamics

4. Global Infectious Disease Point of Care Diagnostics Market Analysis, 2019 - 2023 and Forecast 2024 – 2030

……………….

9. Global Infectious Disease Point of Care Diagnostics Market By Region, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)

10. North America Infectious Disease Point of Care Diagnostics Market, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)

11. Europe Infectious Disease Point of Care Diagnostics Market, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)

12. Asia Pacific (APAC) Infectious Disease Point of Care Diagnostics Market, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)

13. Middle East and Africa (MEA) Infectious Disease Point of Care Diagnostics Market 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)

14. Latin America Infectious Disease Point of Care Diagnostics Market 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)

15. Competition Landscape

16. Research Methodology

17. Appendix and Abbreviations

Scope of The Report:

• The Infectious Disease Point of Care Diagnostics Market research report includes historical data, trending features, and market growth estimates for the future.
• The qualitative and quantitative analysis of the market along with CAGR calculation for the forecast period.
• The market report helps to provide the best results for business enhancement and business growth.
• The report gives a comprehensive overview of both primary and secondary data. ?
• The market key players covered here to help them strengthen their place in the market.